Literature DB >> 7026105

Special considerations in the use of cardiovascular drugs.

K Ueland, J H McAnulty, F R Ueland, J Metcalfe.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7026105     DOI： 10.1097/00003081-198109000-00008

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  5 in total

1.  Treatment of cardiovascular diseases.

Authors:  K R Lees; P C Rubin
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

Review 2.  Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.

Authors:  P Atkins; S B Cohen; B J Phillips
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 3.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

4.  Electrical cardioversion during pregnancy: safe or not?

Authors:  C H N Tromp; A C M Nanne; P J M Pernet; R Tukkie; A C Bolte
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

5.  New-onset lone maternal atrial fibrillation: A case report.

Authors:  Nusrat Batool Janjua; Suhaib Akhtar Birmani; Thomas McDonagh; Abdul Hameed; Matthew McKernan
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.